High efficacy and safety of direct‐acting antivirals for the treatment of chronic hepatitis C: A cohort study conducted in Vietnam

• Egile Nagusiak: Thong Duy Vo (Egilea), Van Thi Thu Bui (Egilea), Huong Tu Lam (Egilea), Quynh Thi Huong Bui (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2024-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Direct‐acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment through their high cure rates and improved safety profiles. We aimed to evaluate the efficacy and safety, and identify the optimal combination, of DAAs for the treatment of chronic HCV. A retrospective stu...